Greg Duncan
2020
In 2020, Greg Duncan earned a total compensation of $3.5M as Chief Executive Officer at Virios Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $2,889,851 |
| Salary | $375,000 |
| Other | $26,943 |
| Total | $3,541,794 |
Duncan received $2.9M in option awards, accounting for 82% of the total pay in 2020.
Duncan also received $250K in non-equity incentive plan, $375K in salary and $26.9K in other compensation.
Rankings
In 2020, Greg Duncan's compensation ranked 3,270th out of 13,090 executives tracked by ExecPay. In other words, Duncan earned more than 75.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,270 out of 13,090 | 75th |
Division Manufacturing | 1,268 out of 5,618 | 77th |
Major group Chemicals And Allied Products | 478 out of 2,251 | 79th |
Industry group Drugs | 414 out of 1,951 | 79th |
Industry Pharmaceutical Preparations | 308 out of 1,456 | 79th |
Source: SEC filing on April 28, 2021.
Duncan's colleagues
We found five more compensation records of executives who worked with Greg Duncan at Virios Therapeutics in 2020.
2020
Richard Burch
Virios Therapeutics
President
2020
William Pridgen
Virios Therapeutics
Chief Executive Officer
2020
Angela Walsh
Virios Therapeutics
Vice President of Finance
2020
Ralph Grosswald
Virios Therapeutics
Vice President of Operations
2020
R Gendreau
Virios Therapeutics
Chief Medical Officer
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021